AIM-listed medical group LiDCO announced US-based healthcare firm NantHealth has developed a communications link between LiDCO's blood analysis monitors and its DeviceConX system.NantHealth's software, DeviceConx, collects and transmits data from medical devices into an electronic record for doctors and patients. The software has been developed in accordance with the regulatory quality system regulation controls and is growing in adoption by hospitals.LiDCO's Chief Executive Terry O'Brien said: "With technology use rising in hospitals, it becomes increasingly important for different systems and equipment to communicate with each other in order to help make informed decisions about patient care. "The communication link for LiDCO's monitors and NantHealth's DeviceConX, will give users another platform from which to access and analyse data, enhancing the utility of LiDCO's monitoring platforms for both our existing and NantHealth's future customers."As of 13:40 LiDCO's share price had risen 1.88% to 19.75p.